相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phosphorylated H2AX in Noninvasive Low Grade Urothelial Carcinoma of the Bladder: Correlation With Tumor Recurrence
Wang L. Cheung et al.
JOURNAL OF UROLOGY (2009)
TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder
Andrew B. Armstrong et al.
MODERN PATHOLOGY (2009)
FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations
Sarah Lott et al.
MODERN PATHOLOGY (2009)
Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer
Carvell T. Nguyen et al.
UROLOGY (2009)
Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur
Francesca Barbisan et al.
CANCER (2008)
Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy
Shahrokh F. Shariat et al.
CANCER (2008)
Identification of side population cells from bladder cancer cells by dyecycle violet staining
Jun Jun She et al.
CANCER BIOLOGY & THERAPY (2008)
Bladder cancer initiating cells (BCICs) are among EMA(-)CD44v6(+) subset: Novel methods for isolating undetermined cancer stem (initiating) cells
Y. M. Yang et al.
CANCER INVESTIGATION (2008)
Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium
A. Lopez-Beltran et al.
JOURNAL OF PATHOLOGY (2008)
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
Ittai Ben-Porath et al.
NATURE GENETICS (2008)
The predictive value of multi-targeted fluorescent in-situ hybridization in patients with history of bladder cancer
Ofer N. Gofrit et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target
Margaret A. Knowles
WORLD JOURNAL OF UROLOGY (2007)
Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis
Timothy D. Jones et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
p53 gene and protein status:: The role of p53 alterations in predicting outcome in patients with bladder cancer
Ben George et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer
D. C. Tomlinson et al.
JOURNAL OF PATHOLOGY (2007)
Knockdown by shRNA identifes S249C mutant FGFR3 as a potential therapeutic target in bladder cancer
D. C. Tomlinson et al.
ONCOGENE (2007)
Phase II trial of sunitinib in bevacizumab-refractory metastatic renal cell carcinoma (mRCC): Updated results and analysis of circulating biomarkers
D. J. George et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Gene expression signatures predict outcome in non-muscle invasive bladder carcinoma:: A multicenter validation study
Lars Dyrskjot et al.
CLINICAL CANCER RESEARCH (2007)
Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract
Matthias Eiber et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer
Yaser Atlasi et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma
Young Deuk Choi et al.
JOURNAL OF UROLOGY (2007)
Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma
Shahrokh F. Shariat et al.
JOURNAL OF UROLOGY (2007)
Gene expression analysis for the prediction of recurrence in patients with primary Ta urothelial cell carcinoma
Iman J. Schultz et al.
EUROPEAN UROLOGY (2007)
Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy
Jose A. Karam et al.
LANCET ONCOLOGY (2007)
P21-activated kinase 1: A new molecular marker for intravesical recurrence after transurethral resection of bladder cancer
Masaaki Ito et al.
JOURNAL OF UROLOGY (2007)
Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease
Vitaly Margulis et al.
CLINICAL CANCER RESEARCH (2006)
Molecular markers of urothelial cancer and their use in the monitoring of superficial urothelial cancer
Peter C. Black et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The p53 pathway and outcome among patients with T1G3 bladder tumors
Elena Lopez-Knowles et al.
CLINICAL CANCER RESEARCH (2006)
Mechanisms of disease - Cancer stem cells
Craig T. Jordan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder
Frank Christoph et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder
Andriy O. Yurakh et al.
EUROPEAN UROLOGY (2006)
Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas
Silvia Hernandez et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Methylation and repeats in silent and nonsense mutations of p53
Sofia Kouidou et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2006)
Transitional cell bladder tumor: predicting recurrence and progression by analysis of microsatellite loss of heterozygosity in urine sediment and tumor tissue
Delfina Fornari et al.
CANCER GENETICS AND CYTOGENETICS (2006)
Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b
I Bernard-Pierrot et al.
CARCINOGENESIS (2006)
Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q
D Lindgren et al.
ONCOGENE (2006)
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
MA Knowles
CARCINOGENESIS (2006)
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays
M Sanchez-Carbayo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses
S Denzinger et al.
HUMAN PATHOLOGY (2006)
Surveillance for recurrent bladder cancer using a point-of-care proteomic assay
HB Grossman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Carcinogen exposure and gene promoter hypermethylation in bladder cancer
CJ Marsit et al.
CARCINOGENESIS (2006)
Why therapeutic response may not prolong the life of a cancer patient - Selection for oncogenic resistance
MV Blagosklonny
CELL CYCLE (2005)
Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma
MG Friedrich et al.
EUROPEAN JOURNAL OF CANCER (2005)
Mechanisms of disease: genetic and EPIGENETIC alterations that drive bladder cancer
EM Wolff et al.
NATURE CLINICAL PRACTICE UROLOGY (2005)
Molecular evidence supporting field effect in urothelial carcinogenesis
TD Jones et al.
CLINICAL CANCER RESEARCH (2005)
FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma
AH Jebar et al.
ONCOGENE (2005)
FGFR3 and Tp53 mutations in T1G3 transitional bladder carcinomas:: Independent distribution and lack of association with prognosis
S Hernández et al.
CLINICAL CANCER RESEARCH (2005)
Increased plasma levels of angiogenin and the risk of bladder carcinoma - From initiation to recurrence
H Zhao et al.
CANCER (2005)
Genetic and epigenetic aspects of bladder cancer
WJ Kim et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Urothelial tumorigenesis: A tale of divergent pathways
XR Wu
NATURE REVIEWS CANCER (2005)
Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens
H Wallerand et al.
CARCINOGENESIS (2005)
Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer
R Stoehr et al.
EUROPEAN UROLOGY (2005)
FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma
BSW van Rhijn et al.
CANCER RESEARCH (2004)
Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma
SJ Chatterjee et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Oligoclonality in bladder cancer: The implication for molecular therapies
BJ Duggan et al.
JOURNAL OF UROLOGY (2004)
Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement
I Frank et al.
CANCER (2004)
Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder:: Use of cDNA array analysis of gene expression profiles
O Modlich et al.
CLINICAL CANCER RESEARCH (2004)
Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome
BWG van Rhijn et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Identifying distinct classes of bladder carcinoma using microarrays
L Dyrskjot et al.
NATURE GENETICS (2003)
The random development of LOH on chromosome 9q in superficial bladder cancers
AAG van Tilborg et al.
JOURNAL OF PATHOLOGY (2002)
Frequent FGFR3 mutations in urothelial papilloma
BWG van Rhijn et al.
JOURNAL OF PATHOLOGY (2002)
Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder
J Edwards et al.
JOURNAL OF PATHOLOGY (2002)
Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor
L Cheng et al.
CANCER (2002)
Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder
J Edwards et al.
BRITISH JOURNAL OF CANCER (2001)
Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest
M Simoneau et al.
ONCOGENE (2000)
Distinct missense mutations of the FCFR3 Lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype
GA Bellus et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Evaluation of p53 protein overexpression, ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder
P Gontero et al.
EUROPEAN UROLOGY (2000)
Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4
KC Hart et al.
ONCOGENE (2000)
Grading and staging of bladder carcinoma in transurethral resection specimens - Correlation with 105 matched cystectomy specimens
L Cheng et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2000)
分享论文
